nach oben

Erschienen in:

01.04.2024 | RESEARCH

Second primary squamous cell carcinoma of the oral cavity – a retrospective cohort study of therapeutic procedures and oncological outcome

verfasst von: Julius Moratin, Theresa Maas, Dominik Horn, Karl Semmelmayer, Sven Zittel, Marcel Oehme, Michael Engel, Jürgen Hoffmann, Christian Freudlsperger, Kolja Freier, Oliver Ristow

Erschienen in: Clinical Oral Investigations | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Objectives

In the presented study, the occurrence rates of second primary oral carcinomas and their prognostic relevance were analyzed.

Materials and methods

All patients with surgically treated oral squamous cell carcinomas within the years 2010 and 2022 in our department were included in this retrospective cohort study. Two groups were designed including patients with second primary carcinomas and patients with local tumor recurrences. Occurrence rates, tumor stages and applied therapies were assessed. Primary outcome was overall survival in dependence of the index tumor. Secondary outcomes were overall survival in dependence of local recurrences or second primary tumors.

Results

An overall number of 908 patients was included in the analysis. 98 patients (10.8%) developed a second primary oral squamous cell carcinoma. Patients with second primary tumors presented significantly (p < 0.001) better overall survival in dependence of the index tumor compared to patients suffering from local recurrences. There was no significant difference in overall survival (p = 0.4) in dependence of the date of second primary tumor or local recurrence. Patients with second primary tumors were more likely to receive surgery-based therapy compared to patients with local recurrences who more frequently received definitive radiotherapy.

Conclusion

Our data indicates different clinical courses in terms of therapy and survival of patients suffering from second primary tumors compared to patients with local tumor recurrences. This may be due to a more aggressive biology of local recurrences and earlier detection of second primaries due to oncological follow-up of the index tumor.

Clinical relevance

The differentiation of local tumor recurrences and second primary tumors is of clinical relevance, as applicable therapies and resulting prognosis may differ significantly.

Siegel RL et al (2021) Cancer Statistics, CA Cancer J Clin, 2021. 71(1): p. 7–33

Shield KD et al (2017) The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin 67(1):51–64CrossRefPubMed

Ferlay J et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed

Nokovitch L et al (2023) Oral cavity squamous cell carcinoma risk factors: state of the art. J Clin Med, 12(9)

Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6(5):963–968CrossRefPubMed

Cooper JS et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944CrossRefPubMed

Moratin J et al (2020) The prognostic significance of the lymph node ratio in oral cancer differs for anatomical subsites. Int J Oral Maxillofac Surg 49(5):558–563CrossRefPubMed

Ferris RL et al (2016) Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med 375(19):1856–1867CrossRefPubMedPubMedCentral

Burtness B et al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet 394(10212):1915–1928CrossRefPubMed

10.

Horn D et al (2020) Prospective feasibility analysis of salvage surgery in recurrent oral cancer in terms of quality of life. Oral Oncol 102:104580CrossRefPubMed

11.

Zittel S et al (2022) Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study. Clin Oral Investig 26(2):2055–2064CrossRefPubMed

12.

Suton P et al (2018) Outcomes for patients with second primary malignancy after primary surgical treatment for early-stage squamous cell carcinoma of the oral cavity. Head Neck 40(11):2347–2352CrossRefPubMed

13.

van der Waal I, de Bree R (2010) Second primary tumours in oral cancer. Oral Oncol 46(6):426–428CrossRefPubMed

14.

Rennemo E, Zatterstrom U, Boysen M (2010) Outcome of local failures after oral cancer - recurrence vs. second primary. J Oral Pathol Med 39(9):657–661CrossRefPubMed

15.

Rogers SN et al (2019) Incidence, timing, presentation, treatment, and outcomes of second primary head and neck squamous cell carcinoma after oral cancer. Br J Oral Maxillofac Surg 57(10):1074–1080CrossRefPubMed

16.

de Vries N, Van der Waal I, Snow GB (1986) Multiple primary tumours in oral cancer. Int J Oral Maxillofac Surg 15(1):85–87CrossRefPubMed

17.

Warren SJAJc (1932) Multiple primary malignant tumors: a survey of the literature and statistical study. 51:1358–1403

18.

Mroueh R et al (2020) Risk of second primary cancer in oral squamous cell carcinoma. Head Neck 42(8):1848–1858CrossRefPubMed

19.

Min SK et al (2019) Second primary cancers in patients with oral cavity cancer included in the Korea Central Cancer Registry. Oral Oncol 95:16–28CrossRefPubMed

20.

Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth 13(Suppl 1):S31–s34CrossRefPubMedPubMedCentral

21.

Tiwana MS et al (2014) Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years. Laryngoscope 124(10):2287–2291CrossRefPubMed

22.

Kaur P et al (2016) A retrospective evaluation of Clinical Profile of Second Primary Head and Neck Cancer. J Clin Diagn Res 10(10):XC10–XC14PubMed

23.

Brands MT et al (2019) Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer. Cancer Med 8(12):5810–5819CrossRefPubMedPubMedCentral

24.

Kesting MR et al (2009) Bronchoscopy screening in primary oral squamous cell carcinoma: a 10-year experience. Br J Oral Maxillofac Surg 47(4):279–283CrossRefPubMed

25.

Kesting MR et al (2009) Results of esophagogastroduodenoscopy in patients with oral squamous cell carcinoma–value of endoscopic screening: 10-year experience. J Oral Maxillofac Surg 67(8):1649–1655CrossRefPubMed

26.

Metzger K et al (2019) Is panendoscopy a necessary staging procedure in patients with lacking risk factors and oral squamous cell carcinoma? J Craniomaxillofac Surg 47(12):1968–1972CrossRefPubMed

27.

Weckx A et al (2019) Time to recurrence and patient survival in recurrent oral squamous cell carcinoma. Oral Oncol 94:8–13CrossRefPubMed

28.

Sun GW et al (2009) Salvage treatment for recurrent oral squamous cell carcinoma. J Craniofac Surg 20(4):1093–1096CrossRefPubMed

29.

Mucke T et al (2009) Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol 45(8):687–691CrossRefPubMed

30.

Masuda M et al (2013) Somatic evolution of head and neck cancer - biological robustness and latent vulnerability. Mol Oncol 7(1):14–28CrossRefPubMed

31.

Leemans CR, Snijders PJF, Brakenhoff RH (2018) The molecular landscape of head and neck cancer. Nat Rev Cancer 18(5):269–282CrossRefPubMed

32.

Johnson DE et al (2020) Head and neck squamous cell carcinoma. Nat Rev Dis Primers 6(1):92CrossRefPubMedPubMedCentral

33.

Horn D et al (2016) Outcome of heavily pretreated recurrent oral squamous cell carcinoma after salvage resection: a monocentric retrospective analysis. J Craniomaxillofac Surg 44(8):1061–1066CrossRefPubMed

34.

Moratin J et al (2021) Full-thickness tumor resection of oral Cancer involving the facial skin-Microsurgical Reconstruction of extensive defects after Radical Treatment of Advanced Squamous Cell Carcinoma. Cancers (Basel), 13(9).

35.

Held T et al (2020) Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial. Radiat Oncol 15(1):190CrossRefPubMedPubMedCentral

36.

Held T et al (2022) Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial. Radiat Oncol 17(1):121CrossRefPubMedPubMedCentral

Titel: Second primary squamous cell carcinoma of the oral cavity – a retrospective cohort study of therapeutic procedures and oncological outcome
verfasst von: Julius Moratin
Theresa Maas
Dominik Horn
Karl Semmelmayer
Sven Zittel
Marcel Oehme
Michael Engel
Jürgen Hoffmann
Christian Freudlsperger
Kolja Freier
Oliver Ristow
Publikationsdatum: 01.04.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 4/2024
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-024-05606-5

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Second primary squamous cell carcinoma of the oral cavity – a retrospective cohort study of therapeutic procedures and oncological outcome